Ondansetron
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70518-3512 -
Package NDC
70518-3512-0 -
Package NDC
70518-3512-1 -
Package NDC
70518-3512-2 -
Package NDC
70518-3512-3 -
Package NDC
70518-3512-4 -
Package NDC
70518-3512-5 -
Package NDC
70518-3512-7 -
Package NDC
70518-3512-8 -
Application number
ANDA078152 -
SPL ID
5ebf5cd9-dfd7-57ee-e063-6294a90a7f1e -
SPL set ID
c0d827d0-333f-4187-ac75-9dc7d34b6169 -
UNII
4AF302ESOS -
RxCUI
104894
What the source publishes
- Labeler
- REMEDYREPACK INC.
- Active ingredients
- Ondansetron
- Form
- TABLET, ORALLY DISINTEGRATING
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Ondansetron",
"splId": "5ebf5cd9-dfd7-57ee-e063-6294a90a7f1e",
"labels": [
{
"setId": "c0d827d0-333f-4187-ac75-9dc7d34b6169",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0d827d0-333f-4187-ac75-9dc7d34b6169",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c0d827d0-333f-4187-ac75-9dc7d34b6169"
}
],
"routes": [
"ORAL"
],
"labeler": "REMEDYREPACK INC.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-0)",
"package_ndc": "70518-3512-0",
"identifierStatus": "well-formed",
"marketing_start_date": "20220907"
},
{
"sample": false,
"description": "6 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-1)",
"package_ndc": "70518-3512-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20220929"
},
{
"sample": false,
"description": "10 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-2)",
"package_ndc": "70518-3512-2",
"identifierStatus": "well-formed",
"marketing_start_date": "20231020"
},
{
"sample": false,
"description": "20 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-3)",
"package_ndc": "70518-3512-3",
"identifierStatus": "well-formed",
"marketing_start_date": "20231031"
},
{
"sample": false,
"description": "12 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-4)",
"package_ndc": "70518-3512-4",
"identifierStatus": "well-formed",
"marketing_start_date": "20231120"
},
{
"sample": false,
"description": "9 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-5)",
"package_ndc": "70518-3512-5",
"identifierStatus": "well-formed",
"marketing_start_date": "20231223"
},
{
"sample": false,
"description": "15 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-7)",
"package_ndc": "70518-3512-7",
"identifierStatus": "well-formed",
"marketing_start_date": "20250306"
},
{
"sample": false,
"description": "3 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-8)",
"package_ndc": "70518-3512-8",
"identifierStatus": "well-formed",
"marketing_start_date": "20250724"
}
],
"productId": "70518-3512_5ebf5cd9-dfd7-57ee-e063-6294a90a7f1e",
"useDomain": "unknown",
"dosageForm": "TABLET, ORALLY DISINTEGRATING",
"productNdc": "70518-3512",
"deaSchedule": null,
"genericName": "Ondansetron",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ONDANSETRON",
"strength": "4 mg/1"
}
],
"applicationNumber": "ANDA078152",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220907",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175817",
"N0000175818"
],
"unii": [
"4AF302ESOS"
],
"rxcui": [
"104894"
],
"spl_set_id": [
"c0d827d0-333f-4187-ac75-9dc7d34b6169"
],
"pharm_class_epc": [
"Serotonin-3 Receptor Antagonist [EPC]"
],
"pharm_class_moa": [
"Serotonin 3 Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"REMEDYREPACK INC."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70518-3512_5ebf5cd9-dfd7-57ee-e063-6294a90a7f1e"